Standout Papers

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone a... 2022 2026 2023 202496
  1. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (2022)
    Christina Tsien, Stephanie L. Pugh et al. Journal of Clinical Oncology

Immediate Impact

1 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

Glioblastoma Therapy: Past, Present and Future
2024 Standout
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
1 intermediate paper

Works of Nimisha Deb being referenced

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
2022 Standout
High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539
2019

Author Peers

Author Last Decade Papers Cites
Nimisha Deb 252 162 47 152 4 477
Edward J. Fudman 95 102 31 77 9 551
Jessie Sullivan 114 43 149 71 5 562
M. Fiorenza 236 37 98 26 12 561
A Iveson 172 57 98 19 8 522
Miklos Pless 168 129 15 16 7 546
Steven Corso 88 286 5 164 9 417
Gina C. Ang 106 101 19 22 7 550
L. E. Abrey 46 41 13 377 6 455
Marc Goldman 26 107 93 61 11 462
Giancarlo Montini 153 101 44 25 7 518

All Works

Loading papers...

Rankless by CCL
2026